Handbook: How to embed CERL into your institution

Autor: Mattila, E., Azevedo, Claudia, Salgado Carreira, Rui, Aleknavičienė, Ana, Strazdienė, Gražina, Moriau, Linde, Morel, Catherine, De Marrée, Jozefien, Tassone, V.C., Pfeiffer, L.H., Eppink, H.J.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4a763b8fb6ec92a7800dfaf46e36f480
https://research.wur.nl/en/publications/handbook-how-to-embed-cerl-into-your-institution

Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug

Autor: Keller, J.J., Vehreschild, M.J.G.T., Hvas, C.L., Jorgensen, S.M.D., Kupciskas, J., Link, A., Mulder, C.J.J., Goldenberg, S.D., Arasaradnam, R., Sokol, H., Gasbarrini, A., Hoegenauer, C., Terveer, E.M., Kuijper, E.J., Arkkila, P., Gridnyev, O., Megraud, F., Kump, P.K., Nakov, R., Satokari, R., Tkatch, S., Sanguinetti, M., Cammarota, G., Dorofeev, A., Gubska, O., Ianiro, G., Mattila, E., Ooijevaar, R.E., Sarin, S.K., Sood, A., Putignani, L., Alric, L., Williams, H.R.T., Goorhuis, A., Verspaget, H.W., Hold, G.L., Tilg, H., Ponsioen, C.Y., Standards Guidelines Initiative

Publikováno v: United European Gastroenterology Journal
United European Gastroenterology Journal, SAGE Publications, 2019, 7 (10), pp.1408-1410. ⟨10.1177/2050640619887579⟩
Keller, J J, Vehreschild, M J GT, Hvas, C L, Jørgensen, S M D, Kupciskas, J, Link, A, Mulder, C J J, Goldenberg, S D, Arasaradnam, R, Sokol, H, Gasbarrini, A, Hoegenauer, C, Terveer, E M, Kuijper, E J, Arkkila, P & On behalf of the UEG working group of the Standards and Guidelines initiative Stool banking for FMT 2019, ' Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug ', United European Gastroenterology Journal, vol. 7, no. 10, pp. 1408-1410 . https://doi.org/10.1177/2050640619887579
United European Gastroenterol J
United European Gastroenterology Journal, 7(10), 1408-1410. SAGE Publications Inc.
Keller, J J, Vehreschild, M JGT, Hvas, C L, Jørgensen, S MD, Kupciskas, J, Link, A, Mulder, C JJ, Goldenberg, S D, Arasaradnam, R, Sokol, H, Gasbarrini, A, Hoegenauer, C, Terveer, E M, Kuijper, E J & Arkkila, P 2019, ' Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug ', United European Gastroenterology Journal, vol. 7, no. 10, pp. 1408-1410 . https://doi.org/10.1177/2050640619887579

International audience; Fecal microbiota transplantation (FMT) or donor feces infusion is a therapy that aims to restore a perturbed gut microbiota composition and function. FMT is effective for treatment of patients with (multiple) recurrent Clostri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2520c9bace964fbb53e4dc929ec1b6ca
https://hdl.handle.net/1887/121712

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Rifaximin in the treatment of recurrent Clostridium difficile infection.

Autor: Mattila, E.¹, Arkkila, P.², Mattila, P. S.³, Tarkka, E.⁴, Tissari, P.⁴, Anttila, V.‐J.¹

Publikováno v: Alimentary Pharmacology & Therapeutics. Jan2013, Vol. 37 Issue 1, p122-128. 7p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.